Your browser doesn't support javascript.
loading
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future.
Spring, Laura M; Wander, Seth A; Andre, Fabrice; Moy, Beverly; Turner, Nicholas C; Bardia, Aditya.
Afiliação
  • Spring LM; Department of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Wander SA; Department of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Andre F; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Moy B; Department of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Turner NC; Department of Medical Oncology, Royal Marsden Hospital, Institute of Cancer Research, London, UK.
  • Bardia A; Department of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: bardia.aditya@mgh.harvard.edu.
Lancet ; 395(10226): 817-827, 2020 03 07.
Article em En | MEDLINE | ID: mdl-32145796
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Inibidores de Proteínas Quinases / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Lancet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Inibidores de Proteínas Quinases / Quinase 4 Dependente de Ciclina / Quinase 6 Dependente de Ciclina Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Lancet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos